Ralf J Ludwig Selected Research

efomycine M

4/2002

Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralf J Ludwig Research Topics

Disease

57	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2023 - 01/2011
43	Bullous Pemphigoid (Pemphigoid) 12/2023 - 12/2010
38	Inflammation (Inflammations) 11/2023 - 04/2002
33	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 04/2010
28	Pemphigus (Pemphigus Vulgaris) 01/2024 - 09/2011
28	Skin Diseases (Skin Disease) 02/2023 - 11/2002
24	Blister (Bulla) 01/2023 - 08/2011
13	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 04/2002
13	Hypersensitivity (Allergy) 07/2017 - 12/2005
10	Neoplasms (Cancer) 09/2023 - 04/2004
8	Thrombocytopenia (Thrombopenia) 07/2017 - 11/2006
7	Infections 02/2024 - 12/2017
6	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 01/2023 - 04/2010
4	Acne Vulgaris 05/2024 - 01/2023
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 09/2006
4	Acantholysis 01/2023 - 02/2012
4	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2018
4	Disease Progression 02/2017 - 02/2016
4	Contact Dermatitis (Eczema, Contact) 03/2010 - 11/2005
3	Thrombosis (Thrombus) 07/2013 - 04/2007
3	Neoplasm Metastasis (Metastasis) 08/2007 - 04/2004
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2024 - 01/2023
2	Myocardial Infarction 01/2023 - 04/2007
2	Virus Diseases (Viral Diseases) 01/2023 - 12/2017
2	Obesity 01/2023 - 07/2017
2	COVID-19 01/2023 - 01/2020
2	Hypertension (High Blood Pressure) 01/2023 - 01/2020
2	Hepatitis 10/2022 - 01/2021
2	Alopecia Areata 01/2022 - 01/2020
2	Tinea Pedis (Athlete's Foot) 01/2022 - 01/2022
2	Hemorrhage 07/2013 - 11/2012
2	Rheumatoid Arthritis 02/2013 - 09/2006
2	Wells syndrome 07/2005 - 05/2003

Drug/Important Bio-Agent (IBA)

88	AutoantibodiesIBA 12/2023 - 06/2010
42	Collagen Type VIIIBA 01/2023 - 01/2011
22	Immunoglobulin G (IgG)IBA 12/2023 - 02/2012
20	AntibodiesIBA 08/2023 - 10/2009
17	Proteins (Proteins, Gene)FDA Link 09/2023 - 11/2011
12	Heparin (Liquaemin)FDA LinkGeneric 07/2017 - 04/2004
11	CytokinesIBA 12/2023 - 02/2013
11	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 04/2010
11	AutoantigensIBA 02/2023 - 01/2012
9	AntigensIBA 01/2023 - 01/2012
8	Complement System Proteins (Complement)IBA 02/2024 - 11/2011
7	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 08/2014
7	P-SelectinIBA 08/2010 - 03/2004
6	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 03/2013
6	Rituximab (Mabthera)FDA Link 01/2023 - 09/2011
6	Therapeutic UsesIBA 01/2022 - 12/2017
6	AnticoagulantsIBA 07/2017 - 04/2004
5	Collagen Type XVIIIBA 11/2023 - 08/2011
5	Fondaparinux (Arixtra)FDA Link 11/2015 - 12/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 01/2023
4	Isotretinoin (Accutane)FDA LinkGeneric 05/2024 - 01/2023
4	Interleukin-17 (Interleukin 17)IBA 11/2023 - 01/2019
4	DesmogleinsIBA 08/2023 - 01/2019
4	Intravenous Immunoglobulins (IVIG)FDA Link 10/2022 - 04/2010
4	anti-type VII collagen autoantibodyIBA 01/2022 - 01/2017
4	Immunoglobulin A (IgA)IBA 12/2021 - 08/2014
4	Peptides (Polypeptides)IBA 12/2021 - 06/2011
4	Immunoglobulin E (IgE)IBA 01/2021 - 11/2015
4	EpitopesIBA 01/2019 - 05/2015
3	dupilumabIBA 04/2024 - 06/2020
3	IgG Receptors (Fc gamma RI)IBA 11/2023 - 01/2017
3	InterleukinsIBA 11/2023 - 01/2023
3	Interleukin-23 (Interleukin 23)IBA 11/2023 - 01/2023
3	IntegrinsIBA 10/2023 - 11/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2022
3	Immunoglobulin M (IgM)IBA 01/2023 - 01/2020
3	Desmoglein 3IBA 12/2022 - 02/2012
3	Interleukin-6 (Interleukin 6)IBA 02/2022 - 02/2013
3	Interleukin-10 (Interleukin 10)IBA 02/2022 - 08/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 08/2014
3	Biomarkers (Surrogate Marker)IBA 12/2017 - 08/2010
3	Nadroparin (Nadroparin Calcium)IBA 07/2017 - 12/2005
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2015 - 01/2013
3	DinitrofluorobenzeneIBA 03/2010 - 08/2006
2	Fas Ligand Protein (Fas Ligand)IBA 01/2024 - 01/2023
2	neonatal Fc receptorIBA 11/2023 - 01/2020
2	Immunodominant EpitopesIBA 11/2023 - 01/2013
2	Imiquimod (Aldara)FDA LinkGeneric 10/2023 - 01/2021
2	SteroidsIBA 02/2023 - 01/2022
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023 - 02/2013
2	LipidsIBA 01/2023 - 01/2017
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023 - 01/2023
2	Azathioprine (Imuran)FDA LinkGeneric 01/2023 - 01/2023
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2022
2	KalininIBA 01/2022 - 03/2013
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2022 - 01/2021
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 04/2010
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 01/2017
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2017
2	Leukotriene B4IBA 01/2017 - 01/2017
2	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 08/2014 - 06/2011
2	Neutralizing AntibodiesIBA 04/2013 - 11/2005
2	SelectinsIBA 04/2007 - 04/2002
2	Enoxaparin (Lovenox)FDA LinkGeneric 03/2006 - 12/2005

Therapy/Procedure

23	Therapeutics 04/2024 - 11/2002
2	Transplantation 10/2023 - 04/2004
2	Precision Medicine 01/2021 - 01/2020